NELSEN ROBERT

10% owner at Neumora Therapeutics, Inc. · on record since Sep 29, 2023
Director at ADOLOR CORP · on record since May 19, 2006
10% owner at BOLD ENERGY INC. · on record since Mar 27, 2024
10% owner at CELEBRATE EXPRESS, INC. · on record since Sep 3, 2008
10% owner at Trubion Pharmaceuticals, Inc · on record since Oct 25, 2006
10% owner at Rapport Therapeutics, Inc. · on record since Jun 10, 2024
Director at NeurogesX Inc · on record since Jun 20, 2007
10% owner at NeurogesX Inc · on record since Jun 20, 2007
10% owner at Maze Therapeutics, Inc. · on record since Jan 30, 2025
10% owner at Metsera, Inc. · on record since Jan 30, 2025
Director at Metsera, Inc. · on record since Nov 14, 2025
10% owner at Kardigan, Inc. · on record since Jun 18, 2026
10% owner at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 1, 2004
Director at Lyell Immunopharma, Inc. · on record since Jun 23, 2021
10% owner at Lyell Immunopharma, Inc. · on record since Jun 23, 2021
10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
10% owner at Seaport Therapeutics, Inc. · on record since Apr 30, 2026
Director at ILLUMINA INC · on record since Dec 1, 2003
10% owner at · on record since Dec 1, 2003
Director at · on record since Oct 16, 2012
10% owner at · on record since Oct 16, 2012
10% owner at · on record since Jun 26, 2013
10% owner at · on record since May 14, 2013
Director at · on record since Jul 31, 2013
10% owner at · on record since Jul 31, 2013
Director at · on record since Sep 30, 2013
10% owner at · on record since Sep 30, 2013
10% owner at · on record since Mar 17, 2014
Director at · on record since Jun 5, 2026
10% owner at · on record since Jun 5, 2026
Director at · on record since Jun 8, 2026
10% owner at · on record since Jun 8, 2026
Director at · on record since Jul 23, 2014
10% owner at · on record since Jul 23, 2014
10% owner at · on record since Aug 4, 2014
Director at · on record since Dec 23, 2014
10% owner at · on record since Dec 23, 2014
Director at · on record since Mar 10, 2004
10% owner at · on record since Mar 10, 2004
Director at · on record since Feb 23, 2015
10% owner at · on record since Feb 23, 2015
See footnote 1 at · on record since Mar 17, 2015
10% owner at · on record since Jun 25, 2015
10% owner at · on record since Oct 28, 2015
10% owner at · on record since Nov 18, 2015
Director at · on record since Jun 29, 2016
10% owner at · on record since Jun 29, 2016
10% owner at · on record since May 25, 2016
10% owner at · on record since Aug 30, 2016
Director at · on record since Jul 26, 2017
10% owner at · on record since Jul 26, 2017
10% owner at · on record since Dec 13, 2017
Director at · on record since Dec 12, 2017
10% owner at · on record since Dec 12, 2017
10% owner at · on record since Mar 27, 2018
10% owner at · on record since May 31, 2018
Director at · on record since May 7, 2018
10% owner at · on record since May 7, 2018
Insider at · on record since Apr 5, 2018
10% owner at · on record since Oct 30, 2018
10% owner at · on record since Feb 12, 2019
Director at · on record since Jun 27, 2019
10% owner at · on record since Jun 27, 2019
Director at · on record since Aug 12, 2019
10% owner at · on record since Aug 12, 2019
Director at · on record since Feb 11, 2020
10% owner at · on record since Feb 11, 2020
10% owner at · on record since Sep 22, 2020
10% owner at · on record since Dec 22, 2020
10% owner at · on record since Oct 20, 2020
Director at · on record since Mar 17, 2021
10% owner at · on record since Jul 27, 2021
10% owner at · on record since Jul 20, 2021
Director at · on record since Jun 24, 2026
Director at · on record since Oct 18, 2019
10% owner at · on record since Oct 18, 2019

Insider trading activity of NELSEN ROBERT

Transactions on record: 465; since Nov 24, 2003

Open-market buys: 29; $129.1M

Open-market sells: 16; $21.2M

Companies traded: 32; last filing Jun 8, 2026

Figures computed from official regulatory filings — .

Companies where NELSEN ROBERT has traded

20 tx · $43.6M · Jun 8, 2026
29 tx · $10M · Jun 5, 2026
10 tx · Jun 17, 2024
3 tx · Jun 10, 2024
92 tx · $20M · Jun 3, 2024
19 tx · $28.4M · Sep 29, 2023
1 tx · Aug 10, 2023
6 tx · Jun 23, 2021
17 tx · Jun 4, 2021
21 tx · $3.2M · Apr 15, 2021
17 tx · Apr 2, 2021
13 tx · Jun 22, 2020
2 tx · Aug 12, 2019
12 tx · $1.1M · Nov 6, 2018
10 tx · Jun 5, 2018

Track record of NELSEN ROBERT

Statistical track record

Free

Open-market buys: 32

Last buy: Aug 1, 2025

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of NELSEN ROBERT

Co-insiders of NELSEN ROBERT

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Prime Medicine, Inc.	Jun 8, 2026	AwardD (derivative)	75,000	0.00 USD	—	SEC
Sana Biotechnology, Inc.	Jun 5, 2026	AwardD (derivative)	90,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	OtherD (derivative)	-45,000	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	OtherD (derivative)	-39,062	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	AwardD (derivative)	39,062	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	AwardD (derivative)	45,000	—	—	SEC
Prime Medicine, Inc.	Aug 1, 2025	Buy	3,030,300	3.30 USD	$10M	SEC
Sana Biotechnology, Inc.	Jun 9, 2025	AwardD (derivative)	80,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Jun 5, 2025	AwardD (derivative)	55,000	0.00 USD	—	SEC
Sana Biotechnology, Inc.	Jul 15, 2024	AwardD (derivative)	65,000	0.00 USD	—	SEC
Lyell Immunopharma, Inc.	Jun 17, 2024	AwardD (derivative)	130,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Jun 14, 2024	AwardD (derivative)	45,000	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	OtherD (derivative)	-20,000,000	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	OtherD (derivative)	-11,924,138	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	Other	3,728,738	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 3, 2024	AwardD (derivative)	16,000	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 3, 2024	Award	8,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Feb 20, 2024	Buy	3,200,000	6.25 USD	$20M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	363,637	5.50 USD	$2M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	727,272	5.50 USD	$4M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	727,272	5.50 USD	$4M	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	16,841	13.06 USD	$219.9K	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	25,110	13.69 USD	$343.8K	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	34,560	13.98 USD	$483.1K	SEC
Neumora Therapeutics, Inc.	Sep 27, 2023	Buy	34,000	11.73 USD	$398.8K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Prime Medicine, Inc.	Jun 8, 2026	AwardD (derivative)	75,000	0.00 USD	—	SEC
Sana Biotechnology, Inc.	Jun 5, 2026	AwardD (derivative)	90,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	OtherD (derivative)	-45,000	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	OtherD (derivative)	-39,062	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	AwardD (derivative)	39,062	—	—	SEC
Prime Medicine, Inc.	Aug 5, 2025	AwardD (derivative)	45,000	—	—	SEC
Prime Medicine, Inc.	Aug 1, 2025	Buy	3,030,300	3.30 USD	$10M	SEC
Sana Biotechnology, Inc.	Jun 9, 2025	AwardD (derivative)	80,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Jun 5, 2025	AwardD (derivative)	55,000	0.00 USD	—	SEC
Sana Biotechnology, Inc.	Jul 15, 2024	AwardD (derivative)	65,000	0.00 USD	—	SEC
Lyell Immunopharma, Inc.	Jun 17, 2024	AwardD (derivative)	130,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Jun 14, 2024	AwardD (derivative)	45,000	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	OtherD (derivative)	-20,000,000	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	OtherD (derivative)	-11,924,138	0.00 USD	—	SEC
Rapport Therapeutics, Inc.	Jun 10, 2024	Other	3,728,738	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 3, 2024	AwardD (derivative)	16,000	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 3, 2024	Award	8,000	0.00 USD	—	SEC
Prime Medicine, Inc.	Feb 20, 2024	Buy	3,200,000	6.25 USD	$20M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	363,637	5.50 USD	$2M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	727,272	5.50 USD	$4M	SEC
Sana Biotechnology, Inc.	Feb 12, 2024	Buy	727,272	5.50 USD	$4M	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	16,841	13.06 USD	$219.9K	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	25,110	13.69 USD	$343.8K	SEC
Neumora Therapeutics, Inc.	Sep 29, 2023	Buy	34,560	13.98 USD	$483.1K	SEC
Neumora Therapeutics, Inc.	Sep 27, 2023	Buy	34,000	11.73 USD	$398.8K	SEC